ID: h-5bf21d2f04
Hypothesis

N-acetylcysteine (NAC) / System Xc⁻ - Mediated GSH Support for Neurovascular Unit Protection

NAC serves as a GSH precursor and direct antioxidant to inhibit ferroptosis in cerebral microvascular endothelial cells and astrocyte end-feet, preserving tight junction integrity and AQP4 polarization to prevent BBB disruption and edema.
🧬 SLC7A11 (system Xc⁻) / GSH metabolism🩺 neurodegeneration🎯 Composite 76%💱 $0.61▼19.5%proposed
EvidencePending (0%)📖 8 cit🗣 1 debates 8 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.75 (15%) Evidence 0.72 (15%) Novelty 0.55 (12%) Feasibility 0.85 (12%) Impact 0.78 (12%) Druggability 0.88 (10%) Safety 0.82 (8%) Competition 0.70 (6%) Data Avail. 0.75 (5%) Reproducible 0.72 (5%) KG Connect 0.50 (8%) 0.760 composite
🏆 ChallengeSolve: N-acetylcysteine (NAC) / System Xc⁻ - Mediated GSH Support for Neurovascu$126K →

🧪 Overview

NAC serves as a GSH precursor and direct antioxidant to inhibit ferroptosis in cerebral microvascular endothelial cells and astrocyte end-feet, preserving tight junction integrity and AQP4 polarization to prevent BBB disruption and edema after cardiac arrest. This is the most translationally credible strategy given NAC's established safety profile, clinical familiarity in critical care, and demonstrated rescue of ferroptosis via GSH precursor pathways. Mechanism attribution to SLC7A11 requires genetic validation (endothelial-specific knockout), but even non-specific antioxidant effects are therapeutically relevant. Preferred compound is NAC itself over unapproved NACA analogs.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["SLC7A11/System Xc-<br/>Cystine-Glutamate Antiporter"]
    B["Cystine Import<br/>Glutathione Precursor Supply"]
    C["Glutathione Synthesis<br/>GPX4 Antioxidant Capacity"]
    D["Lipid Peroxide Detoxification<br/>Ferroptosis Restraint"]
    E["Endothelial Tight Junctions<br/>Barrier Integrity Preserved"]
    F["AQP4 Polarization<br/>Astrocyte End-foot Support"]
    G["Neurovascular Unit Protection<br/>Reduced BBB Leakage"]
    H["SLC7A11 Failure<br/>Oxidative Stress and Ferroptosis"]
    A --> B
    B --> C
    C --> D
    D --> E
    D --> F
    E --> G
    F --> G
    H -.->|"impairs"| A
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style G fill:#1b5e20,stroke:#81c784,color:#81c784
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix8 supports2 contradicts
Supports
NAC rescues ferroptosis via GSH precursor pathway
Supports
SLC7A11 downregulation in ischemia-reperfusion brain injury
Supports
Ferroptosis in endothelial cells drives microvascular dysfunction
Supports
Neurotoxic A1 astrocytes promote neuronal ferroptosis via CXCL10/CXCR3 axis in epilepsy.
Free Radic Biol Med2023PMID:36610561medium
Supports
Promotion of astrocyte-neuron glutamate-glutamine shuttle by SCFA contributes to the alleviation of Alzheimer's disease.
Redox Biol2023PMID:37018970medium
Supports
Mangiferin mitigates neurological deficits and ferroptosis via NRF2/ARE pathway activation in cerebral ischemia-reperfusion rats.
Front Pharmacol2025PMID:40474971medium
Supports
Withaferin A protects against epilepsy by promoting LCN2-mediated astrocyte polarization to stopping neuronal ferroptosis.
Phytomedicine2024PMID:39032282medium
Supports
Voluntary exercise alleviates neural functional deficits in Parkinson's disease mice by inhibiting microglial ferroptosis via SLC7A11/ALOX12 axis.
NPJ Parkinsons Dis2025PMID:40122927medium
Contradicts
NAC has failed in acute ischemic stroke trials despite robust antioxidant effects
Contradicts
NAC crosses BBB poorly; mechanism attribution to SLC7A11 unproven without genetic models
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SLC7A11

No curated PDB or AlphaFold mapping for SLC7A11 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for SLC7A11 (system Xc⁻) / GSH metabolism from GTEx v10.

Amygdala12.1 Caudate basal ganglia11.8 Nucleus accumbens basal ganglia11.8 Anterior cingulate cortex BA2411.1 Cortex10.5 Putamen basal ganglia8.8 Frontal Cortex BA98.7 Substantia nigra7.7 Hippocampus6.6 Spinal cord cervical c-16.5 Hypothalamus6.1 Cerebellum5.5 Cerebellar Hemisphere3.0median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SLC7A11 (system Xc⁻) →

No DepMap CRISPR Chronos data found for SLC7A11 (system Xc⁻).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.6%
Volatility
Low
0.0074
Events (7d)
3
Price History
▼19.5%

💾 Resource Usage

LLM Tokens
12,340
$0.0370
Total Cost
$0.0370

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF C57BL/6 mice are treated with NAC (150 mg/kg i.p.) at 15 minutes after asphyxia-induced cardiac arrest and survive 24 hours, THEN cerebral cortical GSH levels will be ≥40% higher AND 4-HNE immunoreIncreased GSH (≥1.4-fold) and decreased 4-HNE (≤0.5-fold) in cerebral cortex at 24h post-arrest— no observation —pending0.65
IF NAC (150 mg/kg i.p.) is administered at 15 minutes after cardiac arrest in endothelial-specific SLC7A11 knockout mice (Slco1c1-CreERT2;Slc7a11flox/flox, induced with tamoxifen 2 weeks prior), THEN Significantly worse BBB leakage (EvB extravasation ≥1.6-fold higher) in endothelial Slc7a11 KO despite NAC treatment— no observation —pending0.45
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF C57BL/6 mice are treated with NAC (150 mg/kg i.p.) at 15 minutes after asphyxia-induced cardiac arrest and survive 24 hours, THEN cerebral cortical GSH levels will be ≥40% higher AND 4-HNE immunoreactivity (lipid peroxidation) will be ≥50% lower compared to vehicle-treated arrest controls.
Predicted outcome: Increased GSH (≥1.4-fold) and decreased 4-HNE (≤0.5-fold) in cerebral cortex at 24h post-arrest
Falsification: No statistically significant difference in cortical GSH or 4-HNE between NAC and vehicle groups (p > 0.05 by unpaired t-test)
pendingconf 45%
IF NAC (150 mg/kg i.p.) is administered at 15 minutes after cardiac arrest in endothelial-specific SLC7A11 knockout mice (Slco1c1-CreERT2;Slc7a11flox/flox, induced with tamoxifen 2 weeks prior), THEN cortical Evan's blue extravasation at 24h will be ≥60% higher (greater BBB disruption) compared to N
Predicted outcome: Significantly worse BBB leakage (EvB extravasation ≥1.6-fold higher) in endothelial Slc7a11 KO despite NAC treatment
Falsification: No significant difference in Evan's blue extravasation between NAC-treated KO and littermate control mice (p > 0.05), indicating NAC's protection is independent of SLC7A11/system Xc-
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.